4.0 Review

Applicability of explicit potentially inappropriate medication lists to the Australian context: A systematic review

Journal

AUSTRALASIAN JOURNAL ON AGEING
Volume 41, Issue 2, Pages 200-221

Publisher

WILEY
DOI: 10.1111/ajag.13038

Keywords

Australia; pharmacoepidemiology; potentially inappropriate medication list; systematic review

Funding

  1. Deakin University Postgraduate Research Scholarship
  2. NHMRC Early Career Fellowship

Ask authors/readers for more resources

The study aimed to determine the similarity between existing explicit lists of potentially inappropriate medications and their applicability in Australia. The results showed that pooling data from different lists can help identify potentially inappropriate medications applicable to local settings.
Objectives To determine i) the similarity of potentially inappropriate medications specified in and between existing explicit lists and ii) the availability in Australia of medications included on existing lists to determine their applicability to the Australian context. Methods This systematic review identified explicit potentially inappropriate medication lists that were published on EMBASE (1974 - April 2021), MEDLINE (1946 - April 2021) and Elsevier Scopus (2004 - April 2021). The reference lists of seven previously published systematic reviews were also manually reviewed. Lists were included if they were explicit, and the most recent version and the complete list were published in English. Lists based on existing lists were excluded if no new items were added. Potentially inappropriate medications identified on each list were extracted and compared to the medications available on the Australian Register of Therapeutic Goods and Australian Pharmaceutical Benefits Schemes. Results Thirty-five explicit published lists were identified. A total of 645 unique potentially inappropriate medications were extracted, of which 416 (64%) were available in Australia and 262 (41%) were subsided by the general Pharmaceutical Benefits Scheme. Applicability of each explicit list ranged from 50-96% according to medications available in Australia and 25-83% according to medications available under subsidy. Conclusions Pooling data from different lists may help to identify potentially inappropriate medications that may be applicable to local settings. However, if selecting a list for use in the Australian context, consideration should also be given to the intended purpose and setting for application.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available